WO2006036936A3 - The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents - Google Patents

The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents Download PDF

Info

Publication number
WO2006036936A3
WO2006036936A3 PCT/US2005/034529 US2005034529W WO2006036936A3 WO 2006036936 A3 WO2006036936 A3 WO 2006036936A3 US 2005034529 W US2005034529 W US 2005034529W WO 2006036936 A3 WO2006036936 A3 WO 2006036936A3
Authority
WO
WIPO (PCT)
Prior art keywords
indanyl
phenylamino
piperidine
isomer
ethyl
Prior art date
Application number
PCT/US2005/034529
Other languages
French (fr)
Other versions
WO2006036936A2 (en
Inventor
Gunnar Aberg
Jan L Chen
Original Assignee
Bridge Pharma Inc
Gunnar Aberg
Jan L Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc, Gunnar Aberg, Jan L Chen filed Critical Bridge Pharma Inc
Publication of WO2006036936A2 publication Critical patent/WO2006036936A2/en
Publication of WO2006036936A3 publication Critical patent/WO2006036936A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

The present invention relates to the S-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep.
PCT/US2005/034529 2004-09-27 2005-09-27 The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents WO2006036936A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61338604P 2004-09-27 2004-09-27
US60/613,386 2004-09-27

Publications (2)

Publication Number Publication Date
WO2006036936A2 WO2006036936A2 (en) 2006-04-06
WO2006036936A3 true WO2006036936A3 (en) 2006-10-19

Family

ID=36119520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034529 WO2006036936A2 (en) 2004-09-27 2005-09-27 The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents

Country Status (2)

Country Link
US (2) US7718674B2 (en)
WO (1) WO2006036936A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301826B2 (en) 2008-02-18 2016-04-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
US9393002B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5645361B2 (en) 2005-08-02 2014-12-24 エクスバイオテク インコーポレーティッド Diagnosis, treatment and prevention of vascular disorders using IL-1α autoantibodies
US20110218218A1 (en) * 2005-09-23 2011-09-08 Bridge Pharma, Inc. Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US8317808B2 (en) 2008-02-18 2012-11-27 Covidien Lp Device and method for rolling and inserting a prosthetic patch into a body cavity
US9833240B2 (en) 2008-02-18 2017-12-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9034002B2 (en) 2008-02-18 2015-05-19 Covidien Lp Lock bar spring and clip for implant deployment device
US9398944B2 (en) 2008-02-18 2016-07-26 Covidien Lp Lock bar spring and clip for implant deployment device
US9044235B2 (en) 2008-02-18 2015-06-02 Covidien Lp Magnetic clip for implant deployment device
US8808314B2 (en) 2008-02-18 2014-08-19 Covidien Lp Device and method for deploying and attaching an implant to a biological tissue
US8758373B2 (en) 2008-02-18 2014-06-24 Covidien Lp Means and method for reversibly connecting a patch to a patch deployment device
ES2797126T3 (en) 2008-05-30 2020-12-01 Xbiotech Inc IL-1 alpha antibody uses
CN102209557A (en) 2008-09-12 2011-10-05 埃克斯生物科技公司 Targeting pathogenic monocytes
EP2337502B1 (en) 2008-10-20 2014-08-06 Covidien LP A device for attaching a patch to a biological tissue
BRPI0922224A2 (en) 2008-12-08 2016-08-02 Vm Pharma Llc receptor protein tyrosine kinase inhibitor compositions.
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
WO2010129542A1 (en) * 2009-05-04 2010-11-11 Jie Zhang Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8906045B2 (en) 2009-08-17 2014-12-09 Covidien Lp Articulating patch deployment device and method of use
WO2011021082A1 (en) 2009-08-17 2011-02-24 PolyTouch Medical, Inc. Means and method for reversibly connecting an implant to a deployment device
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US20110117175A1 (en) * 2009-11-18 2011-05-19 Rosenbaum Richard J Sweet analgesic for use in medical procedures or treatments
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US20110311547A1 (en) * 2010-06-18 2011-12-22 Xbiotech, Inc. Arthritis Treatment
EP2608808B1 (en) 2010-08-23 2017-01-18 XBiotech, Inc Treatment for neoplastic diseases
US20120100125A1 (en) * 2010-10-26 2012-04-26 Kyphon Sarl Local dehydration for carpal tunnel syndrome
EP3363437B8 (en) * 2011-02-18 2021-11-03 Endo Pharmaceuticals Inc. Aminoindane compounds and use thereof in treating pain
US9724409B2 (en) 2011-04-01 2017-08-08 Xbiotech, Inc. Treatment of inflammatory skin disease
RU2622021C2 (en) 2011-09-23 2017-06-08 ИксБиотеч, Инк. Cachexia therapy
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
HUE032240T2 (en) 2011-10-24 2017-09-28 Asana Biosciences Llc Cyclohexylamines
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
WO2014028675A1 (en) * 2012-08-15 2014-02-20 Endo Pharmaceuticals Inc. Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
US9545441B2 (en) 2012-09-18 2017-01-17 Xbiotech, Inc. Treatment of diabetes
US8999992B2 (en) 2013-03-15 2015-04-07 Vm Pharma Llc Crystalline forms of tryosine kinase inhibitors and their salts
EP3035903B1 (en) 2013-08-20 2018-08-22 Anutra Medical, Inc. Syringe fill system and method
EP3086785A4 (en) * 2014-01-01 2017-08-30 Real Time Imaging Technologies, LLC Improved local anesthetic solution for dental and/or contrast media use
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
US10301271B2 (en) * 2014-09-17 2019-05-28 Purdue Pharma L.P. Crystalline forms of tyrosine kinase inhibitors and their salts
WO2016115117A1 (en) 2015-01-12 2016-07-21 Real Time Imaging Technologies, Llc Low-dose x-ray imaging system
WO2017066787A1 (en) * 2015-10-17 2017-04-20 Lebedyeva Iryna O Compounds, compositions, and methods of making and using the same
KR20190117579A (en) 2017-02-16 2019-10-16 엑스바이오테크, 인크. Treatment of purulent hanitis
WO2019071246A2 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for controlled release of analgesics to treat postoperative pain, and associated devices, systems, and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923815A (en) * 1972-11-06 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindane thereof
US6413987B1 (en) * 1999-06-10 2002-07-02 Bridge Pharma, Inc. Dermal anesthetic agents

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760018A (en) 1969-12-19 1971-06-08 Christiaens Sa A NEW DERIVATIVES OF 2-AMINO-INDANE, THEIR PREPARATION AND THEIR USE
US3923813A (en) 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
AR206505A1 (en) 1972-09-18 1976-07-30 Christiaens Sa A PROCEDURE TO OBTAIN NEW DERIVATIVES OF N-PHENYL-N-AMINOALKYL-2-AMINOINDANE
GB1440440A (en) 1972-10-06 1976-06-23 Manuf Prod Pharma Tetrahydronaphthalene derivatives
GB1462036A (en) 1973-02-05 1977-01-19 Manuf Prod Pharma Aminoindane derivatives
AR208282A1 (en) 1973-03-01 1976-12-20 Christiaens Sa A PROCEDURE FOR PREPARING DERIVATIVES OF 2- (N-PHENYL - (- AMINOALKYL) -AMINOINDANE
IL44292A (en) 1973-03-01 1977-04-29 Christiaens Sa A Preparation of 2-aminoindane derivatives
GB1468347A (en) 1973-03-02 1977-03-23 Christiaens Sa A Aminoindanes
LU74197A1 (en) 1976-01-16 1977-07-22
DE3226753A1 (en) 1982-07-14 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Wound bandage to take up wound secretions
US4942175A (en) 1987-04-24 1990-07-17 Schick Laboratories, Inc. Composition for the treatment of substance abuse
FI95572C (en) 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
US4822597A (en) 1987-07-13 1989-04-18 Warner-Lambert Company Anesthetic-containing chewing gum compositions
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5061700A (en) 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
JP2849950B2 (en) 1990-11-30 1999-01-27 日東電工株式会社 Transdermal formulation
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
JPH07157424A (en) 1993-12-03 1995-06-20 Lintec Corp Gel formulation for local anesthesia
WO1996009829A1 (en) 1994-09-27 1996-04-04 Virotex Corporation Improved topical carriers for mucosal applications
WO1996033706A1 (en) 1995-04-28 1996-10-31 Pharmetrix, Inc. Compositions and methods for inducing dermal analgesia
DE19524691A1 (en) 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Method and composition of topical therapy for inner ear and labyrinth symptoms
DE19526031A1 (en) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Method and composition of a topical therapy for back pain and muscle tension
DE19526019A1 (en) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Method and composition of a topical therapy for headache
US5968536A (en) 1995-10-11 1999-10-19 Godfrey; Marjorie M. Device for applying topical anesthetic
US5667799A (en) 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
JP2791317B2 (en) 1995-12-26 1998-08-27 株式会社三和化学研究所 Multilayer film preparation
SE9601421D0 (en) 1996-04-12 1996-04-12 Astra Ab New composition
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
AU5095698A (en) 1996-10-25 1998-05-15 Copley Pharmaceutical Inc. Transdermal patch
DK0971713T3 (en) 1997-03-03 2003-09-22 Eisai Co Ltd Use of cholinesterase inhibitors to treat attention disorders
US6103771A (en) 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
CA2299950C (en) 1999-03-03 2010-09-21 Nitto Denko Corporation Oral adhesive sheet and oral adhesive preparation
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US6762158B2 (en) 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
EP2133078A1 (en) 2000-03-03 2009-12-16 Eisai R&D Management Co., Ltd. Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US20020022052A1 (en) 2000-04-06 2002-02-21 Dransfield Charles William Transdermal delivery system
AU2001261516A1 (en) 2000-05-11 2001-11-20 Advanced Polymer Systems Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
JP4459414B2 (en) 2000-08-24 2010-04-28 日東電工株式会社 Oral patch preparation
WO2002089849A1 (en) 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US20030082225A1 (en) 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
US20030124174A1 (en) 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20030091619A1 (en) 2001-11-14 2003-05-15 Spencer Jamison R. Temporomandibular joint patch
US20030175328A1 (en) 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
EP1517709B1 (en) 2002-06-20 2008-06-11 Amnon Sintov Transdermal drug delivery system
US7241456B2 (en) 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
AU2003298710B2 (en) 2002-11-26 2008-02-07 Endo Pharmaceuticals Inc. Composition and its use for treating neuropathic sensory loss

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923815A (en) * 1972-11-06 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindane thereof
US6413987B1 (en) * 1999-06-10 2002-07-02 Bridge Pharma, Inc. Dermal anesthetic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BURGER A.: "Medicinal Chemistry", 1970, WILEY INTERSCIENCE, pages: 81 - 82 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301826B2 (en) 2008-02-18 2016-04-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
US9393002B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Also Published As

Publication number Publication date
US7718674B2 (en) 2010-05-18
WO2006036936A2 (en) 2006-04-06
US20060079559A1 (en) 2006-04-13
US20100179114A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
WO2006036936A3 (en) The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2006037047A3 (en) The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2006049734A3 (en) Quetiapine analogs and methods of use thereof
WO2005105110A3 (en) Doxepin analogs and methods of use thereof
ZA200804030B (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
NO20050884D0 (en) New Process for the Synthesis of Ivabradine and its Addition Salts with a Pharmaceutically Acceptable Acid
WO2005102335A3 (en) Methods of treating sleep disorders
TWI370131B (en) New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
UA100501C2 (en) Carboxamide compounds and their use as calpain inhibitors
IL180371A0 (en) Method of treating sjogren's syndrome
NO20050883L (en) New Process for the Synthesis (IS) -4,5-Dimethoxy-1- (methylaminomethyl) -benzocyclobutane and Addition Salts thereof, and Use in the Synthesis of Ivabradine and Addition Salts thereof with a Pharmaceutically Acceptable Acid
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
ATE524479T1 (en) SULFONAMIDTHIAZOLEPYRIDINE DERIVATIVES AS GLUCOKINASE ACTIVATIONS SUITABLE FOR THE TREATMENT OF TYPE 2 DIABETES
WO2002074758A3 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
EA200400881A1 (en) AZAARILPIPERAZINS
ATE448219T1 (en) NEW HYDANTOIN DERIVATIVES FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
JO3021B1 (en) 4-[4-({[ 4- chloro-3- (trifluoromethyl) phenyl] carbamoyl}lamino)-3- fluoromethyl]-N-methylpyridine -2- carboxamide monohydrate
HK1080456A1 (en) N-substituted hydromorphones and the use thereof
GB9902047D0 (en) Chemical compounds XI
WO2005075450A3 (en) Spiro-benzodioxoles and their use as cb1 antagonists
WO2006021000A3 (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
WO2004041272A3 (en) Use of serotonin receptor antagonists for the treatment of sleep apnea
NO20050888L (en) New Process for the Synthesis of 1,3,4,5-Tetrahydro-2H-3-Benzazepin-2-One Compounds, and Use in the Synthesis of Ivabradine and Addition Salts thereof with a Pharmaceutically Acceptable Acid
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
EP1539136A4 (en) Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05807636

Country of ref document: EP

Kind code of ref document: A2